APA (7th ed.) Citation

Kong, A. M., Lucia, J., Christoph, M. J., Mordi, U., Joseph, D., Askin, G., . . . Lim, T. (2026). Real-World Persistence After Starting Bictegravir- or Dolutegravir-Based Regimens Among Adults Aged ≥50 Years with HIV in the United States. Drugs & Aging, 43(2), 175. https://doi.org/10.1007/s40266-026-01279-9

Chicago Style (17th ed.) Citation

Kong, Amanda M., et al. "Real-World Persistence After Starting Bictegravir- or Dolutegravir-Based Regimens Among Adults Aged ≥50 Years with HIV in the United States." Drugs & Aging 43, no. 2 (2026): 175. https://doi.org/10.1007/s40266-026-01279-9.

MLA (9th ed.) Citation

Kong, Amanda M., et al. "Real-World Persistence After Starting Bictegravir- or Dolutegravir-Based Regimens Among Adults Aged ≥50 Years with HIV in the United States." Drugs & Aging, vol. 43, no. 2, 2026, p. 175, https://doi.org/10.1007/s40266-026-01279-9.